Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

kenneth-newman_credit_verona_pharma

Verona Pharma loses Chief Medical Officer

April 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, verona pharma

Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …
Appointment
csm_packshot_kineret_814229b3fc

Sobi receives expanded EU approval for Kineret

April 11, 2018 Research and Development, Sales and Marketing Kineret, anti-inflammatory, biotech, drugs, pharma, pharmaceutical, sobi

Joining its current indication as a treatment for rheumatoid arthritis and cryopyrin-associated periodic syndromes, Sobi’s Kineret has been given approval …
News

Alexion $855m portfolio boost after Wilson Therapeutics buyout

April 11, 2018 Research and Development, Sales and Marketing Alexion, Wilson's Therapeutics, Wilson's disease, biotech, drugs, pharma, pharmaceutical

Alexion Pharmaceuticals is badly in need of alternative revenue streams to Soliris, its mega-blockbuster that could start to face competition …
News
mylan

Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment

April 11, 2018 Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …
News
fighting_cancer

Looking to the future of oncology

April 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma

The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …
Feature
800px-prostate_cancer_1

Almost 40% of UK prostate cancer cases are diagnosed late, according to report

April 9, 2018 Medical Communications, Research and Development, Sales and Marketing Cancer, UK, pharma, prostate cancer

A report conducted by charity Orchid has revealed a “worrying trend” in the treatment of prostate cancer, indicating that as …
News
instagram-3198093_960_720

Facebook takes action against drug peddlers on Instagram

April 9, 2018 Medical Communications, Sales and Marketing Facebook, biotech, drugs, fentanyl, instagram, opioid, opioid epidemic, pharma, pharmaceutical

Facebook can’t catch a break at the moment, after being widely criticised for its practices over the security of users’ …
News
roche_glass_building

Tecentriq third time lucky after NICE nod in lung cancer

April 9, 2018 Sales and Marketing NICE, Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq

After having been knocked by twice by NICE, Roche has finally received a recommendation for Tecentriq’s second-line use in non-small …
News
merckincweb

Keytruda combo fails at Phase 3 in metastatic melanoma

April 9, 2018 Research and Development, Sales and Marketing Incyte, MSD, keytruda, pharma, trial failure

Shares in biopharma firm Incyte were sent reeling by as much as 20% when the company announced that the results …
News

Novartis CEO makes mark with $8.7bn AveXis acquisition

April 9, 2018 Sales and Marketing AveXis, Novartis, biotech, drugs, gene therapy, pharma, pharmaceutical

Vas Narasimhan’s first few moves as CEO of Novartis indicate that he is not afraid to take bold risks in …
News
humira_abbott__4

Samsung Bioepis and Biogen secure licensing deal with Abbvie for Humira biosimilar

April 6, 2018 Medical Communications, Sales and Marketing AbbVie, Biogen, Humira, Imraldi, Samsung Bioepis, biosimilar, pharma

Partners Biogen and Samsung Bioepis have secured the future of their Humira (adalimumab) biosimilar after penning a deal with Abbvie …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

April 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …
News
roche_close

Roche suffers Ocrevus knockback by NICE

April 6, 2018 Medical Communications, Sales and Marketing Ocrevus, Roche, biotech, drugs, multiple sclerosis, pharma, pharmaceutical

Roche’s multiple sclerosis drug, Ocrevus (ocrelizumab), has been a big new growth driver for the company, especially in the US, …
News
shutterstock_274590824

J&J pays out $37m in damages over claims its talc contains asbestos

April 6, 2018 Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, mesothelioma, ovarian cancer, pharma, talc

Bad news for Johnson & Johnson as it emerges that the US pharma giant has been ordered to pay out …
News
china_block_001_takeda

Takeda move for Shire looks increasingly likely

April 6, 2018 Medical Communications, Sales and Marketing Japan, Shire, Takeda, UK, biotech, drugs, pharma, pharmaceutical

Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical about …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025